Challenges and Strategies for
Complex Molecules from a CMC Perspective
Presenter:
Yang Li, PhD
Vice President of CMC Development,
Altruist Biologics, an Innovent CDMO
Yang Li, PhD, is the vice president of CMC development at Altruist Biologics, bringing over 10 years of industry expertise in biological drug and vaccine development, manufacturing and registration.
Previously, he held key roles as vice president of CMC development at Innovent Biologics and chief technology officer at Clover Biopharmaceuticals, where he spearheaded product development initiatives. His background includes significant contributions at Bristol-Myers Squibb and Celgene, focusing on upstream process development. Dr. Li has played a pivotal role in the registration of two biologics and led over 20 IND submissions across multiple global markets, while holding a doctoral degree in biological engineering from the Massachusetts Institute of Technology.
